Last deal

Amount

Series C

Stage

31.01.2014

Date

4

all rounds

$2.7M

Total amount

General

About Company
Mode Diagnostics utilizes biomarkers' electrochemical properties to develop innovative home diagnostic assays.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company leverages a suite of technologies, including assay development techniques, biosensing capabilities, microfabrication, electronics, and wireless communications, to create user-friendly health screening products for physicians and consumers. Their proprietary platform, measure, offers a flexible, low-cost, and hygienic solution for creating health tests. Their first product, measure BOWEL HEALTH, revolutionizes bowel cancer screening by providing significant improvements over current testing methods. Mode Diagnostics aims to provide efficient and accurate diagnostic products for measuring and screening bowel health, benefiting both physicians and patients.
Contacts

location

Phone number

Social url